Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study: Masimo's monitor diagnoses carbon monoxide poisoning

This article was originally published in Clinica

Executive Summary

Masimo’s noninvasive carboxyhaemoglobin (SpCO) test can help diagnose carbon monoxide (CO) poisoning at the scene of an emergency, a study has found. The test is carried out using the company’s Masimo Rad-57 Pulse CO-Oximeter, which employs a sensor that is placed on a patient’s finger. Previously, the only way of measuring CO poisoning was via a blood test, Masimo (Irvine, California) claims. In the case study, published in the January-March 2010 issue of Prehospital Emergency Care, firefighters responding to an emergency used the SpCO test to identify patients with elevated CO levels, who were then treated with oxygen. It also helped to find the source of the CO poisoning, which was not immediately apparently with atmospheric CO testing.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT045174

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel